EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Gilead Sciences, Inc. $GILD Shares Bought by Mn Services Vermogensbeheer B.V.
Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
6,329 Shares in Gilead Sciences, Inc. $GILD Acquired by WESPAC Advisors LLC
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Gilead Sciences, Inc. $GILD Stake Lifted by USA Financial Formulas
5,845 Shares in Gilead Sciences, Inc. $GILD Bought by Parsons Capital Management Inc. RI - Stock Observer
Synergy Asset Management LLC Has $204,000 Holdings in Gilead Sciences, Inc. $GILD
Exchange Traded Concepts LLC Raises Position in Gilead Sciences, Inc. $GILD
Wedge Capital Management L L P NC Sells 10,133 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
CAR T-Cell Therapy Market to Hit USD 13.78 Billion by 2031, Driven by Rising Global Cancer Prevalence - Insights by Product, Target, Indication, Demographic, Region, and Competitive Landscape
Gilead Sciences FY2026 EPS Increased by Erste Group Bank
NatWest Group plc Has $5.40 Million Stock Holdings in Gilead Sciences, Inc. $GILD
FY2026 EPS Forecast for Gilead Sciences Lifted by Analyst - Stock Observer
Gilead Sciences, Inc. $GILD Shares Purchased by Global X Japan Co. Ltd. - Daily Political
A Look At Gilead Sciences (GILD) Valuation After Recent Share Price Weakness
Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline
Metastatic Triple-Negative Breast Cancer Market: Strong Growth Potential Across APAC Through 2036, Driven by Innovation and Rising Disease Burden | DelveInsight
Czech National Bank Buys 12,009 Shares of Gilead Sciences, Inc. $GILD
17,800 Shares in Gilead Sciences, Inc. $GILD Acquired by Pensionfund Sabic - Markets Daily
Pensionfund Sabic Takes $2.19 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Eyes $2.2 Billion Autoimmune Push With Ouro Deal
Gilead Expands Into Autoimmune With Ouro Deal And Galapagos Alliance
Rights to antibody drug by China's Keymed change hands in Gilead acquisition of Ouro | South China Morning Post
Gilead pens dual-purpose $2B Ouro M&A deal with Galapagos | BioWorld
Gilead Sciences Acquires Ouro Medicines for Over $2 Billion to Expand Immunology Pipeline, ETPharma
Dow Jones Top Company Headlines at 9 PM ET: Estee Lauder in Talks to Acquire Spain's Puig to Create Global Beauty Giant | Gilead ... | Morningstar
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets - Update | Morningstar
Gilead to buy Ouro Medicines for up to $2.2 billion
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion | Morningstar
Gilead to buy biotech firm Ouro Medicines in over $2 billion deal
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos en Gilead in vergevorderde gesprekken over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen
-- Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cel
Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
Demand surges in Nigeria for new HIV prevention injection ahead of rollout | Africanews
Wealth Enhancement Advisory Services LLC Has $77.22 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Nordea Investment Management AB Has $630.06 Million Stake in Gilead Sciences, Inc. $GILD
Henrickson Nauta Wealth Advisors Inc. Purchases 7,074 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Nordea Investment Management AB Increases Position in Gilead Sciences, Inc. $GILD - Stock Observer
IAM Advisory LLC Takes $1.27 Million Position in Gilead Sciences, Inc. $GILD
BCGM Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD
Union Bancaire Privee UBP SA Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest
Groupama Asset Managment Grows Stock Holdings in Gilead Sciences, Inc. $GILD
Anderson Hoagland & Co. Purchases New Stake in Gilead Sciences, Inc. $GILD
AIA Group Ltd Increases Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Wilmington Savings Fund Society FSB - Daily Political
GILD: HIV Franchise And Oncology Expansion Will Shape Bullish Long Term Outlook
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd
Johanna Mercier Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - Markets Daily
Swiss Life Asset Management Ltd Purchases 31,807 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Sunbelt Securities Inc. Trims Holdings in Gilead Sciences, Inc. $GILD - Daily Political
A Look At Gilead Sciences (GILD) Valuation As Recent Returns Send Mixed Signals
Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD
Captrust Financial Advisors Has $211.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V.
Gilead Sciences, Inc. $GILD Holdings Cut by WBI Investments LLC - Daily Political
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares
Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock
Fort Point Capital Partners LLC Sells 8,153 Shares of Gilead Sciences, Inc. $GILD
CSM Advisors LLC Sells 42,400 Shares of Gilead Sciences, Inc. $GILD
Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push - Stock Observer
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and "long cycle" growth - Daily Political
2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 15.7% in February
Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - Daily Political
Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD
BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Brokerages - Markets Daily
Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD
Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Upgraded by Wall Street Zen to Strong-Buy Rating
BNP Paribas Sells 16,020 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer
Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen
Harvest Fund Management Co. Ltd Has $10.34 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - Daily Political
Dodge & Cox Reduces Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead News
Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact
Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors
US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning
Investing in US Stocks from South Africa: Step-by-Step Guide for ZA Investors
How to Invest in Stocks for Beginners (Europe): Opportunities, Risks and Smart Strategies in 2026
Forex Market Today: BRICS+ Currency Dynamics, USD/AED Stability, Key Currency Trading Opportunities
European Stocks Overview: European Shares Slide as Middle East Conflict Fuels Inflation Fears
Latest news
Show moreUkraine Forges New Alliances in the Middle East, Leveraging Defense Expertise
Fed Policy Pivot: Inflation Risks Hint at Potential Rate Hikes, Shifting Market Expectations
TotalEnergies Dominates Middle East Oil Market in March, Securing Record Profits
Navigating Economic Crosscurrents: Market Outlook Amidst Geopolitical Turmoil
Ukraine Hints at Reduced Strikes on Russian Energy Amid Partner Pressure, Secures Middle East Support
